Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: March 10, 2016
Reporting Period: Quarter and year ended December 31, 2015
This filing serves to announce the Company's financial results for the specified period. The detailed financial data is contained within a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) but are not present in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only confirms the announcement of results for the quarter and year ended December 31, 2015.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release containing the full text of the financial results announcement.
Legal Disclaimer: The information furnished in this report, including Exhibit 99.1, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2016) for specific revenue, net loss, and cash position figures.
- Verify the Company's cash runway and burn rate as disclosed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm the status of any outstanding debt or financing arrangements referenced in the full financial results.